Cybin Inc. (CYBN)
NYSEAMERICAN: CYBN · Real-Time Price · USD
6.27
-0.46 (-6.84%)
Sep 8, 2025, 4:00 PM - Market closed
Cybin Market Cap
Cybin has a market cap or net worth of $147.97 million as of September 8, 2025. Its market cap has decreased by -26.41% in one year.
Market Cap
147.97M
Enterprise Value
73.78M
1-Year Change
-26.41%
Ranking
Category
Stock Price
$6.27
Market Cap Chart
Since November 11, 2020, Cybin's market cap has increased from $91.10M to $147.97M, an increase of 62.43%. That is a compound annual growth rate of 10.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 147.97M | -16.12% |
| Dec 31, 2024 | 176.41M | 4.62% |
| Dec 29, 2023 | 168.63M | 199.71% |
| Dec 30, 2022 | 56.26M | -72.57% |
| Dec 31, 2021 | 205.14M | 4.86% |
| Dec 31, 2020 | 195.64M | 114.76% |
| Nov 11, 2020 | 91.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 652.84B |
| Johnson & Johnson | 429.72B |
| AbbVie | 375.50B |
| UnitedHealth Group | 285.64B |
| AstraZeneca | 253.68B |
| Novartis AG | 252.55B |
| Novo Nordisk | 244.67B |
| Abbott Laboratories | 231.38B |